4th Annual Dry AMD Therapeutic Development Summit Hilton Boston Logan Airport, Boston
There’s significant momentum in the clinical and preclinical pipeline for dry AMD, backed by record-breaking investments and acquisitions. This was further demonstrated by the landmark first approval in February this year. The question for the field now is – what’s next?
Uniting 100+ experts across biotech and pharma who are actively developing drugs that have the potential to revolutionize treatment of dry AMD, the 4th Annual Dry AMD Therapeutic Development Summit is back this November to answer that very question.
Find out more in the event guide – https://ter.li/gf8ab7
Dry AMD therapeutic development is the hottest topic in the ocular space right now. Join us to accelerate the drug pipeline and revolutionize dry AMD treatment for millions of patients in the US and worldwide.
Register to attend – https://ter.li/4mdotb